Mark A. Schenerman
Mark A. Schenerman publishes mostly in Molecular Biology, Radiology, Nuclear Medicine and Imaging and Biomedical Engineering, on topics such as Protein purification and stability, Monoclonal and Polyclonal Antibodies Research and Advanced biosensing and bioanalysis techniques.
- World rank
- #1,360,762 of 7,710,434 ranked researchers
- Rank in United States
- #430,917 of 1,627,098
- Works
- 40
- Citations
- 2.1k
- Citations per work
- 53.1
What does Mark A. Schenerman research?
Mark A. Schenerman's work is mostly in Biochemistry, Genetics and Molecular Biology (29%), Medicine (15%), Engineering (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1947.0%
- Life Sciences1229.1%
- Health Sciences615.4%
- Medicine615.4%
- Physical Sciences38.5%
- Engineering25.1%
- Chemistry13.4%
- 1Molecular Biology29% of their works
- 2Radiology, Nuclear Medicine and Imaging7% of their works
- 3Biomedical Engineering5% of their works
- 4Epidemiology4% of their works
- 5Infectious Diseases4% of their works
- 6Organic Chemistry3% of their works
Research topics
- Protein purification and stability
- Monoclonal and Polyclonal Antibodies Research
- Advanced biosensing and bioanalysis techniques
- Viral Infectious Diseases and Gene Expression in Insects
- Viral gastroenteritis research and epidemiology
- Gold and Silver Nanoparticles Synthesis and Applications
- Virus-based gene therapy research
- Glycosylation and Glycoproteins Research
Which keywords describe Mark A. Schenerman's research?
The keywords of their largest research topics: Monoclonal Antibodies, Therapeutic Antibodies, Glycosylation, Biopharmaceuticals, Protein Aggregation, Antibody Engineering, Fc Receptors and DNA nanotechnology.
- Glycans
- Cancer
- Gold Nanoparticles
- Rotavirus
- Norovirus
- DNA nanotechnology
- Antibody Engineering
- Biopharmaceuticals
- Therapeutic Antibodies
- Monoclonal Antibodies
- Glycosylation
- Protein Aggregation
- Fc Receptors
- Mammalian Cells
- Recombinant Protein
- Self-Assembly
- Plasmonic Nanoparticles
- Gene Therapy
- Viral Vectors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Monoclonal Antibodies192 topics
- Therapeutic Antibodies192 topics
- Glycosylation163 topics
- Biopharmaceuticals111 topic
- Protein Aggregation111 topic
- Antibody Engineering81 topic
- Fc Receptors81 topic
- DNA nanotechnology51 topic
- Mammalian Cells51 topic
- Norovirus51 topic
- Recombinant Protein51 topic
- Rotavirus51 topic
- Self-Assembly51 topic
- Gold Nanoparticles41 topic
- Plasmonic Nanoparticles41 topic
- Cancer31 topic
- Gene Therapy31 topic
- Glycans31 topic
- Viral Vectors31 topic
Where does Mark A. Schenerman work?
Mark A. Schenerman's main affiliation in the publication record is Altimmune (United States), United States.
How many publications and citations does Mark A. Schenerman have?
OpenAlex counts 40 works and 2,122 citations for Mark A. Schenerman, an h-index of 17, ranking #1,360,762 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mark A. Schenerman. Posts are plain text and can be reported.